• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Computational Toxicology

FDA Center for Drug Evaluation and Research (CDER) records are a unique repository of the results of clinical and non-clinical studies and post-marketing clinical adverse events. With major advances in computers and information technology, this unique scientific and regulatory information resource can now be more effectively used to address pre- and post-marketing issues. These issues include improving the scientific basis of regulatory actions, supporting guidance development, and contributing to the general advancement of science and product development.